WELLS FARGO & COMPANY/MN - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 36 filers reported holding REGULUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$55,000
-77.8%
282,186
-24.9%
0.00%
Q2 2018$248,000
-10.1%
375,972
-2.2%
0.00%
Q1 2018$276,000
-32.2%
384,538
-1.9%
0.00%
Q4 2017$407,000
-33.8%
392,142
-20.3%
0.00%
Q3 2017$615,000
-10.6%
492,191
-29.5%
0.00%
Q2 2017$688,000
-46.7%
698,390
-10.7%
0.00%
Q1 2017$1,291,000
-16.7%
782,380
+13.5%
0.00%
-100.0%
Q4 2016$1,550,000
-25.5%
689,085
+9.3%
0.00%0.0%
Q3 2016$2,081,000
+41.0%
630,332
+23.4%
0.00%0.0%
Q2 2016$1,476,000
-47.8%
510,664
+25.2%
0.00%0.0%
Q1 2016$2,826,000
+18.8%
407,724
+49.5%
0.00%0.0%
Q4 2015$2,378,000
+37.7%
272,652
+3.3%
0.00%0.0%
Q3 2015$1,727,000
-37.0%
264,037
+5.5%
0.00%0.0%
Q2 2015$2,742,000
-55.7%
250,188
-31.5%
0.00%0.0%
Q1 2015$6,188,000
+123.9%
365,378
+112.0%
0.00%0.0%
Q4 2014$2,764,000
+116.1%
172,345
-8.0%
0.00%0.0%
Q3 2014$1,279,000
-23.6%
187,277
-9.9%
0.00%0.0%
Q2 2014$1,673,000
+11.0%
207,970
+24.5%
0.00%0.0%
Q1 2014$1,507,000
+70.3%
167,015
+39.4%
0.00%
Q4 2013$885,000
+5.1%
119,768
+34.1%
0.00%
Q3 2013$842,000
+90.5%
89,331
+98.5%
0.00%
Q2 2013$442,00045,0140.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders